Symkevi/Kalydeco cleared for use in young CF patients
The combination is the first available to treat the underlying cause of CF in this patient group.
27th November 2020
Latest news
EU to review Merck's targeted lung cancer drug
Tepotinib could be the first treatment on the market for NSCLC in adults harbouring METex14 skipping alterations
27th November 2020
NICE turns down Novartis' Adakveo
Trial results and cost-effectiveness are too uncertain for NHS use, the Institute said
27th November 2020
NHS to trial innovative cancer blood test
It is hoped that the test will help detect cancer at a much earlier stage
27th November 2020
NICE backs use of new treatment for multiple myeloma
Sanofi's Sarclisa gets the final green light for use by the NHS with funding from the CDF
26th November 2020
Moderna signs deal with EU for 160 million COVID-19 vaccine doses
Delivery of vaccine doses to EU could begin by early 2021
26th November 2020
Janssen's Tremfya approved for active psoriatic arthritis
Tremfya is a first-in-class treatment for the disease, shown to improve disease measures and quality of life
26th November 2020
Mixed reaction to chancellor's spending review
Chancellor Rishi Sunak hands out extra £3 billion to NHS and £14.6 billion in funding for R&D
26th November 2020
COVID-19 pandemic has emphasised existing health inequalities, research finds
New report conducted by Imperial College London researchers and Philips UK highlights issues within the NHS
25th November 2020
BMS inks drug discovery deal with Schrödinger
Deal will focus on developing small molecules against a number of diseases
25th November 2020
Over half of pharmacists report that COVID-19 has impacted their mental health
Survey from The Royal Pharmacy Society shows impact of pandemic on pharmacists’ mental health
25th November 2020
GSK launches late-stage study of RSV vaccine in pregnant mothers
Shot will be evaluated in pregnant mothers and their newborn infants
25th November 2020
Amgen hands back heart failure programme rights to Cytokinetics
Omecamtiv mecarbil and AMG 594 rights transitioned back to biotech
24th November 2020
NICE backs Braftovi for BRAF-positive colorectal cancer
Positive recommendation follows initial rejection in September
24th November 2020
FDA approves new dosing option for AZ’s Imfinzi
Less-frequent, fixed-dose use approved for two cancer indications
24th November 2020
